Merck against counterfeiting, no more fake drugs thanks to Blockchain
In our previous post we explained the associated benefits of being able to track information within the chain, posing different cases and markets as a reference. This time we bring you an example that is happening in reality, reflecting what was stated in the post.
Merck and the Pharmaceutical Industry
The pharmaceutical giant, Merck, is seeking a patent to use Blockchain to track goods as they move along the supply chain.
Published last Thursday and submitted in December 2016, the patent application describes a method by which a chain of blocks could be used to store information about a physical object, in this case, a single product, and receive updates as advances from its point of origin. That distributed network could be used to store information that verifies the authenticity of the article.
The goal of the distributor is to reduce the amount of counterfeit products, seeking to ensure the quality of the drugs offered and take care of their customers.
The pharmaceutical industry explains :
"Allows secure and reliable storage of reading results with very high data integrity, so that it is essentially impossible to manipulate or erase, or otherwise reduce or lose that data gradually, for example, due to intentional or deliberate deletion or due to data corruption. "
"In addition, you can access stored information where access to the block chain is available. This allows secure and distributed storage and access to stored read results, for example, for integrity verification purposes, such as checking if a product supplier is marked with a composite security mark, as described here, was made the creator of the product, or not. "
The company is a member of the Enterprise Ethereum Alliance, with a representative of the firm that leads the group's health care work group when it was launched last year.